Benitec Biopharma (BNTC) Capital Expenditures Growth (1y) (2021 - 2023)

Benitec Biopharma (BNTC) Capital Expenditures Growth (1y) (2021 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -22.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 9.68%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -37.81%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -34.23%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 22,433.30%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 142.64%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -73.62%
10 Benitec Biopharma 577.39 Mn 388.49 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -92.31%
Jun 30, 2022 109.22%
Jun 30, 2021 -1,184.62%